Specifications include, but are not limited to: 5 PANEL NON-DOT: 3.1.1.1 Vendor must provide 5 Panel Non-DOT test that covers: Marijuana Metabolites, Cocaine Metabolites, Opioids, Amphetamines, and Phencyclidine (PCP).; 3.1.1.2 Concentrations of a drug at or above the following levels shall be considered a positive test regarding the initial immunoassay drug-screening test: 1. Cocaine Metabolite 300 ng/ml; 2. Marijuana Metabolite 50 ng/ml; 3. Opiate Metabolite 300 ng/ml; Codeine; Morphine; 6-am (heroin); 3.1.1.3. Concentrations of a drug at or above the folliwng levels shall be considered a positive test regarding the confirmatory gas chromatography /mass spectrometry (GC/MS) test: 1. Cocaine Metabolite 150 ng/ml; 2. Marijuana Metabolite 15 ng/ml; 3. Opiate Metabolite 300 ng/ml; Codeine; Morphine; 6-am (heroin);